Abstract
This article reviews the surgical considerations of cardiac allograft rejection after heart transplantation and describes current treatment modalities for the failing graft. Cardiac allograft rejection can be a moribund diagnosis, especially when it is acute and high grade. It is broadly categorized into hyperacute, acute cellular, and antibody-mediated rejection. Treatment includes a multitude of medical and immunomodulation therapies for graft recovery. Severe rejection requires mechanical circulatory support for hemodynamic stability to maintain end-organ function. Retransplantation for graft loss is the ultimate therapy; however, it portends poor outcomes.
Original language | English (US) |
---|---|
Pages (from-to) | 59-63 |
Number of pages | 5 |
Journal | Cardiovascular Pathology |
Volume | 42 |
DOIs | |
State | Published - Sep 1 2019 |
Keywords
- Acute cellular rejection
- Antibody-mediated rejection
- Cardiac allograft rejection
- Graft rejection
- Heart transplantation
- Mechanical circulatory support
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Cardiology and Cardiovascular Medicine